Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_assertion type Assertion NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_head.
- NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_assertion description "[Comprehensive genomic profiling of relapsed CDH1-mutated ILC revealed actionable genomic alterations in 86% of cases, featured a high incidence of ERBB2 alterations, and can reveal actionable alterations that can inform treatment decisions for patients with ILC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_provenance.
- NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_assertion evidence source_evidence_literature NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_provenance.
- NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_assertion SIO_000772 23575477 NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_provenance.
- NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_assertion wasDerivedFrom befree-2016 NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_provenance.
- NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_assertion wasGeneratedBy ECO_0000203 NP1068229.RARpxfpJht_t1Id7n1u93mXjdtGkcU7Zb1Y3dXqaN1Xkc130_provenance.